New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
10:04 EDTSNYSanofi appoints Dr. Gary J. Nabel as Chief Scientific Officer
Sanofi announced the appointment of Dr. Gary J. Nabel, M.D., Ph.D., Senior Vice President, Chief Scientific Officer and Deputy to the President for Global R&D, effective December 3. Dr. Nabel will report to Dr. Elias Zerhouni, President, Global R&D, and will join the groupís Global Leadership Team. He will be based in Cambridge, Massachusetts. Dr. Nabel joins Sanofi from the National Institutes of Health, where he served as Director of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases since 1999.
News For SNY From The Last 14 Days
Check below for free stories on SNY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
07:11 EDTSNYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
July 16, 2014
09:03 EDTSNYSanofi held talks on mature drugs with Abbott, Mylan, PE firms, Reuters says
Sanofi (SNY) has shopped an $8.5B portfolio of mature drugs to Abbott (ABT), Mylan (MYL) and private equity firms, according to Reuters, citing an internal company document circulated by the CGT union. Sanofi is considering whether to sell, carve out or create a joint venture for the portfolio of about 200 drugs, but a Sanofi spokesman said no decision has yet been made, the report noted. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use